TrumpRx.gov has expanded to over 800 discounted medications, adding 160 new prescription drugs to the government-backed platform announced Friday by President Trump. The expansion, the second in as many months, brings the total number of commonly-used medications available at reduced prices to more than 800, according to Fox News and The Hill.
“I am pleased to announce that TrumpRx.gov is adding another 160 Prescription Drugs, at highly discounted prices, for a new total of over 800 of the most commonly-used Prescription Drugs,” Trump wrote on Truth Social. The president also claimed the program will now provide discounted offerings for four out of every five prescriptions filled by Americans.
The latest additions come just weeks after billionaire investor Mark Cuban participated in a White House rollout of 600 new generic drugs on the platform in May 2026. Cuban said at the time that his own discount drug company, Cost Plus Drugs, was integrating its medication lists with TrumpRx to expand consumer access to lower-cost options.
How the Most Favored Nation Policy Works
TrumpRx was built to facilitate the Trump administration’s “most favored nation” (MFN) pricing policy, which aims to tie U.S. drug prices to the lowest prices paid in other developed countries. Under this framework, pharmaceutical manufacturers agree to price medications competitively with what other high-income nations pay, according to the White House and multiple health policy sources.
The platform launched in February 2026 with 43 branded prescription drugs after the administration negotiated agreements with 16 major pharmaceutical companies. Companies including Eli Lilly, Novo Nordisk, Pfizer, AstraZeneca, and EMD Serono have agreed to participate in the MFN arrangements, offering discounts on medications for asthma, infertility, obesity, diabetes, and other conditions.
TrumpRx now features two distinct lists: “presidential deals” for branded medications and “standard prices” for generic drugs. Users can search the website for medications, view estimated savings, and generate coupons to use at participating pharmacies or directly through manufacturers’ websites, according to Fox News reporting.
Trump claimed in his June announcement that the MFN deals have already saved American patients over $400 million since TrumpRx launched. The president also attributed the pricing agreements partly to his use of tariffs, saying tariffs encouraged other countries to “pay up” and helped secure lower prices for U.S. consumers. “Of course, Most Favored Nations would not be possible without my use of TARIFFS,” he wrote, arguing that Americans had been “ripped off” for decades on drug pricing.
The expansion reflects the administration’s broader effort to lower prescription drug costs, which Trump has framed as a priority. Health and Human Services Secretary Robert F. Kennedy Jr. has previously asserted that the U.S. had been paying two to four times as much for medications as other countries, a gap the administration is working to close through the MFN policy.
Sources
- The Hill — reported Trump’s June 6, 2026 announcement of 160 new drugs and over 800 total medications on TrumpRx.gov
- Fox News — confirmed the expansion details and Trump’s claims about savings and tariff-related agreements
- The White House — provided fact sheets on the MFN pricing policy and TrumpRx launch in February 2026
- AP News — reported on the May 2026 addition of 600+ generic medications to the platform
